Intuitive Surgical (ISRG) CMO logs 10b5-1 option exercises and stock sales

Rhea-AI Filing Summary

Intuitive Surgical EVP & Chief Medical Officer Myriam Curet reported option exercises and stock sales in Intuitive Surgical, Inc. common stock. On January 27, 2026, she exercised options for 105 shares at $229.39 and 125 shares at $208.90, then sold 105 shares and 125 shares at $532.61 per share.

The filing notes these trades occurred under a Rule 10b5-1 trading plan that expires on July 29, 2026. After these transactions, the report shows 251 and 1,362 non-qualified stock options remaining directly held and 353 common shares held indirectly by a trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Curet Myriam

(Last) (First) (Middle)

1020 KIFER ROAD

(Street)

SUNNYVALE CA 94086

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/27/2026		M(1)		105	A	$229.39	105	D
Common Stock	01/27/2026		S(1)		105	D	$532.61	0	D
Common Stock	01/27/2026		M(1)		125	A	$208.9	125	D
Common Stock	01/27/2026		S(1)		125	D	$532.61	0	D
Common Stock								353	I	by Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$208.9	01/27/2026		M(1)			125	(2)	08/28/2029	Common Stock	125	$0.0	251	D
Non-Qualified Stock Option (right to buy)	$229.39	01/27/2026		M(1)			105	(3)	02/27/2030	Common Stock	105	$0.0	1,362	D

Explanation of Responses:

1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.

2. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

3. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

	By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet	01/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ISRG EVP & Chief Medical Officer Myriam Curet report on this Form 4?

She reported exercising stock options and selling Intuitive Surgical common shares. On January 27, 2026, she exercised 105 and 125 options and sold the resulting 105 and 125 shares, all as part of a pre-arranged Rule 10b5-1 trading plan.

How many Intuitive Surgical (ISRG) shares did Myriam Curet sell and at what price?

She reported selling 105 shares and 125 shares of Intuitive Surgical common stock. Both sale transactions were executed at a reported price of $532.61 per share on January 27, 2026, immediately after exercising corresponding stock options.

What option exercises did Myriam Curet disclose for Intuitive Surgical (ISRG)?

She exercised non-qualified stock options for 105 shares at $229.39 and 125 shares at $208.90. These options relate to Intuitive Surgical common stock and were followed by same-day sales of the underlying shares at $532.61 per share.

Is Myriam Curet’s Intuitive Surgical trading under a Rule 10b5-1 plan?

Yes. The filing states the transactions took place under a Trading Plan that complies with SEC Rule 10b5-1. This plan, which schedules trades in advance, is disclosed as expiring on July 29, 2026.

What Intuitive Surgical (ISRG) equity interests does Myriam Curet report holding after these trades?

She reports remaining non-qualified stock options and indirect common share holdings. Following the reported transactions, the form shows 251 and 1,362 option units directly held and 353 Intuitive Surgical common shares held indirectly through a trust.

How do the Intuitive Surgical (ISRG) options granted to Myriam Curet vest?

One option grant vests 7/48 one month after grant, then 1/48 monthly. Another grant vests 12.5% six months after February 10, 2023, with the remainder vesting in forty-two equal monthly installments, contingent on continued service.